Nls-Rar Alpha Promotes Proliferation And Inhibits Differentiation In Hl-60 Cells

Xiu-Xiu Hu,Liang Zhong,Xi Zhang,Yuan-Mei Gao,Bei-Zhong Liu
DOI: https://doi.org/10.7150/ijms.6518
2014-01-01
International Journal of Medical Sciences
Abstract:A unique mRNA produced in leukemic cells from a t(15; 17) acute promyelocytic leukemia (APL) patient encodes a fusion protein between the retinoic acid receptor alpha (RAR alpha) and a myeloid gene product called PML. Studies have reported that neutrophil elastase (NE) cleaves bcr-1-derived PML-RAR alpha in early myeloid cells, leaving only the nuclear localization signal (NLS) of PML attached to RAR alpha. The resultant NLS-RAR alpha fusion protein mainly localizes to, and functions within, the cell nucleus. It is speculated that NLS-RAR alpha may act in different ways from the wild-type RAR alpha, but its biological characteristics have not been reported. This study takes two approaches. Firstly, the NLS-RAR alpha was silenced with pNLS-RAR alpha-shRNA. The mRNA and protein expression of NLS-RAR alpha were detected by RT-PCR and Western blot respectively. Cell proliferation in vitro was assessed by MTT assay. Flow cytometry (FCM) was used to detect the differentiation of cells. Secondly, the NLS-RAR alpha was over-expressed by preparation of recombinant adenovirus HL-60/pAd-NLS-RAR alpha. The assays of mRNA and protein expression of NLS-RAR alpha, and cell proliferation, were as above. By contrast, cell differentiation was stimulated by all trans retinoic acid (ATRA) (2.5 mu mol/L) at 24h after virus infection of pAd-NLS-RAR alpha, and then detected by CD11b labeling two days later. The transcription and translation of C-MYC was detected in HL-60/pAd-NLS-RAR alpha cells which treated by ATRA. Our results showed that compared to the control groups, the expression of NLS-RAR alpha was significantly reduced in the HL-60/pNLS-RAR alpha-shRNA cells, and increased dramatically in the HL-60/pAd-NLS-RAR alpha cells. The proliferation was remarkably inhibited in the HL-60/pNLS-RAR alpha-shRNA cells in a time-dependent manner, but markedly promoted in the HL-60/pAd-NLS-RAR alpha cells. FCM outcome revealed the differentiation increased in HL-60/pNLS-RAR alpha-shRNA cells, and decreased in the HL-60/pAd-NLS-RAR alpha cells treated with 2.5 mu mol/L ATRA. The expression of C-MYC increased strikingly in HL-60/pAd-NLS-RAR alpha cells treated with 2.5 mu mol/L ATRA. Down-regulation of NLS-RAR alpha expression inhibited the proliferation and induced the differentiation of HL-60 cells. On the contrary, over-expression of NLS-RAR alpha promoted proliferation and reduced the ATRA-induced differentiation of HL-60 cells.
What problem does this paper attempt to address?